Maya Deepti Srinivasan MD
Assistant Professor, Hematology & Medical Oncology
72 East Concord Street | (617) 638-6500mdsriniv@bu.edu
Sections
Hematology & Medical Oncology
Biography
Dr. Maya D. Srinivasan, MD, MSc, is a Hematologist and Medical Oncologist specializing in the care of patients with lymphomas. Her clinical and research interests lie at the intersection of global health and oncology, with a strong commitment to reducing oncologic disparities worldwide. She is particularly focused on advancing care for patients with virally-mediated lymphomas, including Adult T-cell Leukemia/Lymphoma, EBV-associated lymphomas, and HIV-associated lymphomas. Dr. Srinivasan is dedicated to developing and expanding access to tolerable, effective, and novel therapeutic regimens, with the goal of improving outcomes and equity in lymphoma care globally.
Education
MD, St. George's University School of Medicine
MSc, University of Southern California School of Medicine
Global Health, BA, Northwestern University
Publications
Dittus C, Weinstock MJ, Barnes J, Sandoval-Sus J, Grover NS, Beaven A, Hoye K, Shelton A, Tan X, Srinivasan MD, El-Jawahri A, Sarosiek S, Sloan JM. Final results of a multicentre pilot study evaluating brentuximab vedotin with cyclophosphamide, doxorubicin, etoposide and prednisone (BV-CHEP) for the treatment of aggressive adult T-cell leukaemia/lymphoma. Br J Haematol. 2025 Jun 03. PMID: 40459047.
Published on 11/5/2024Bodanapu G, Corrigan J, Culnan J, Srinivasan M, Hora M, Lazzaro A, Yildirim C, Elbers D, Lang D, Do N, Brophy M, Bell B, Szalat RE, Munshi NC, Fillmore NR, Edwards CV. Risk Factors for Suboptimal Treatment in Patients with Newly Diagnosed Multiple Myeloma across US Healthcare Systems. Risk Factors for Suboptimal Treatment in Patients with Newly Diagnosed Multiple Myeloma across US Healthcare Systems. 2024; 144(Blood):3341.
Published on 11/5/2024Srinivasan MD, Dittus C, El-Jawahri A, Jain S, Shelton A, Sloan JM. Mogamulizumab Combinations in Patients with Relapsing/Refractory Adult T-Cell Leukemia/Lymphoma (r/r ATLL). Mogamulizumab Combinations in Patients with Relapsing/Refractory Adult T-Cell Leukemia/Lymphoma (r/r ATLL). 2024; 144(Blood):6405.
Published on 2/1/2021Abramson M, Glezerman IG, Srinivasan M, Ross R, Flombaum C, Gutgarts V. Hypophosphatemia and FGF23 tumor-induced osteomalacia in two cases of metastatic breast cancer. Clin Nephrol. 2021 Feb; 95(2):104-111. PMID: 33191899.
Published on 12/14/2020Saggi SJ, Nath S, Culas R, Chittalae S, Burza A, Srinivasan M, Abdul R, Silver B, Lora A, Ibtida I, Chokshi T, Capric V, Mohamed A, Worah S, OuYang J, Geraghty P, Gruessner A, Salifu MO. Early Experience With Methylprednisolone on SARS-CoV-2 Infection in the African American Population, a Retrospective Analysis. Clin Med Insights Circ Respir Pulm Med. 2020; 14:1179548420980699. PMID: 33402859.